Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma
Findings from St. Jude Children’s Research Hospital show that cell-free DNA in cerebrospinal fluid can be used to detect measurable residual disease and identify patients at risk of relapse.
-
Changing tumor cell identity
Scientists at St. Jude and Dana-Farber Cancer Institute learned how retinoic acid changes tumor cells in children with high-risk neuroblastoma.
-
Promising preclinical cancer therapy harnesses a newly discovered cell death pathway
Results offer clues for enhancing interferon effectiveness in cancer treatment.
-
Powered by St. Jude, Together, a Web-Based Patient Education Resource on Childhood Cancer, Plans to Launch in Seven New Languages
Together by St. Jude announces plans to launch in seven new languages, offering trustworthy medical information about pediatric cancer and shared stories of hope to families around the world.
-
Accumulated DNA damage linked to neurodegeneration in a rare pediatric disorder
St. Jude Children’s Research Hospital scientists have identified the disease process that underlies Aicardi-Goutières syndrome, a debilitating illness with no known cure.
-
Figuring out how T cells interpret signals
St. Jude scientists are studying how cytokines that promote inflammatory responses affect T cells.